Analysed INTENSITY THERAPEUTICS INC (INTS:NASDAQ) News Sources
Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update
27-03-2026
yahoo.com
Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US
24-03-2026
yahoo.com
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
12-03-2026
yahoo.com
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement
06-03-2026
yahoo.com
Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities
13-01-2026
yahoo.com
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy
15-12-2025
yahoo.com
Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium
11-12-2025
yahoo.com
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
05-12-2025
yahoo.com
What is the current price of INTENSITY THERAPEUTICS INC (INTS:NASDAQ)?
The current price of INTENSITY THERAPEUTICS INC (INTS:NASDAQ) is $5.51.
INTENSITY THERAPEUTICS INC (INTS:NASDAQ) absolute price change since previous trading day?
The absolute price change of INTENSITY THERAPEUTICS INC (INTS:NASDAQ) since the previous trading day is $-0.09.
INTENSITY THERAPEUTICS INC (INTS:NASDAQ) percentage price change since previous trading day?
The percentage price change of INTENSITY THERAPEUTICS INC (INTS:NASDAQ) since the previous trading day is -1.6071%.
What is the most recent average sentiment score for INTENSITY THERAPEUTICS INC (INTS:NASDAQ)?
The most recent average sentiment score for INTENSITY THERAPEUTICS INC (INTS:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for INTENSITY THERAPEUTICS INC (INTS:NASDAQ)?
The most recent sentiment for INTENSITY THERAPEUTICS INC (INTS:NASDAQ) is .
SEC-8K** Filing Available For INTENSITY THERAPEUTICS INC (INTS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.